{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-172076","form_type":"8-K","ticker":"WAT","cik":"0001000697","company_name":"WATERS CORP /DE/","filed_at":"2025-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.100430+00:00","generated_at":"2026-05-17T21:18:36.727523+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Waters Q2 sales $771M (+9% reported, +8% CC); GAAP EPS $2.47, non-GAAP $2.95; raises FY guidance","bullets":["Sales $771M, up 9% reported and 8% constant currency vs $709M prior year.","GAAP EPS $2.47; non-GAAP EPS $2.95, up 12% YoY, above guidance mid-point.","Pharma segment grew 11% CC; Industrial +6%; Academic/Government declined 3%.","Raising FY2025 constant currency sales growth guidance to +5.5% to +7.5%; non-GAAP EPS $12.95-$13.05.","Q3 2025 guidance: constant currency sales growth +5.0% to +7.0%; non-GAAP EPS $3.15-$3.25."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-172076","json":"https://secwatch.observer/filing/0001193125-25-172076.json","markdown":"https://secwatch.observer/filing/0001193125-25-172076.md","text":"https://secwatch.observer/filing/0001193125-25-172076.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1000697/000119312525172076/0001193125-25-172076-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1000697/000119312525172076/d26754d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T21:18:36.727523+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}